TEVA News and Press, Teva Pharmaceutical Industries Limited American Depositary Shares From 03/02/26

2026-03-02 15:20:00 ET When you think "top-performing pharma stock," Eli Lilly may first come to mind. Yet while Lilly's shares have surged over the past few years, they've only gained around 14% over the past year. Contrast that with Teva Pharmaceutical Industries (NYSE: TEVA...

2026-02-27 18:42:00 ET Teva Pharmaceutical Industries (NYSE: TEVA) is an interesting investment story. For the right investor, it could be an attractive buy. For me, however, it isn't. Here's the opportunity that Teva has ahead of it, and why that opportunity just doesn't interest m...

2026-02-26 19:05:00 ET The following segment was excerpted from the Allspring SMID Cap Growth Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Allspring Smid Cap Growth Fund Q4 2025 Top Contribu...

2026-02-24 19:07:46 ET On February 17, 2026, Bridger Management, LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold all of its Bath & Body Works (NYSE:BBWI) shares in the fourth quarter. According to an SEC filing dated February 17, 2026...

PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in the upcoming investor conferences in March as follows: UBS European Healthcare...

2026-02-23 08:30:00 ET In my last article, "Novo Nordisk: Will Wegovy And Pipeline Spark Rally?" , I mostly discussed Novo Nordisk's (NONOF) ( NVO ) Q3 results and the efficacy of 20 mg amycretin and UBT251.... Read the full article on Seeking Alpha For further detai...

2026-02-21 09:09:02 ET More on Teva Pharmaceutical, Royalty Pharma, etc. Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results - Slideshow Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Mai...

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation 1 If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by address...

2026-02-20 07:30:47 ET In January, I rated Corcept Therapeutics ( CORT ) a Hold , citing severe binary risk of its looming patent appeal against Teva Teva Pharmaceutical Industries ( TEVA ). On February 19th, the US Court of Appeals for the Federal Circuit ...

2026-02-20 00:45:00 ET The following segment was excerpted from the Allspring Mid Cap Growth Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Allspring Mid Cap Growth Fund Q4 2025 Performance In...